Abstract
Vertigo is an illusion of movement and may result from peripheral vestibular disease, vestibular migraine, central neurological disorders, cardiovascular or metabolic causes, medications and other systemic conditions. Because potentially serious central causes may mimic benign vestibular syndromes, accurate clinical assessment must precede therapeutic individualisation. This narrative review summarises the clinical classification, major causes, diagnostic approach, red flags, conventional management principles and the role proposed for homoeopathic individualisation. Traditional materia-medica associations are discussed separately from clinical efficacy evidence. Available studies of homoeopathic preparations for vertigo are limited and heterogeneous; evidence for selected complex preparations cannot automatically be extrapolated to classical individualised prescribing. A responsible homoeopathic approach should therefore integrate careful case-taking with appropriate diagnosis, referral and monitoring. Current evidence does not establish individualised homoeopathy as a proven treatment for all forms of vertigo. Future research requires clearly defined diagnoses, transparent prescribing, validated outcomes, appropriate controls and adequate follow-up.
Keywords: Vertigo; dizziness; BPPV; vestibular migraine; Ménière's disease; homoeopathy; individualisation; vestibular disorders.
Introduction
Vertigo is a common clinical complaint encountered in primary care, emergency medicine, neurology and otorhinolaryngology. Patients may describe spinning, rotation, swaying, rocking, tilting or a sensation of being pulled toward one side. The symptom may be brief and positionally triggered, recurrent over months, or acute and persistent. Its causes range from benign vestibular disorders to posterior circulation stroke and other central neurological disease.
For homoeopathic practice, this diversity has an important implication: the disease label alone is insufficient for safe management, while symptom individualisation should not replace diagnostic evaluation. A clinically useful approach combines timing and triggers, focused examination, recognition of red flags and, where appropriate, individualised complementary treatment.
Clinical Classification and Major Causes
A timing-and-triggers framework divides vestibular presentations into triggered episodic, spontaneous episodic, acute continuous and chronic persistent syndromes. Triggered episodic vertigo is classically seen in benign paroxysmal positional vertigo (BPPV). Spontaneous episodic attacks occur in conditions such as vestibular migraine and Ménière's disease. Acute continuous vertigo may represent vestibular neuritis but can also occur with cerebellar or brainstem stroke. Chronic imbalance may occur in bilateral vestibulopathy, persistent postural-perceptual dizziness, neurological disease or multisensory impairment.
BPPV is caused by abnormal displacement of otoconia into a semicircular canal. Typical attacks last seconds and are precipitated by turning in bed, lying down, rising, looking upward or bending. Posterior-canal BPPV is the commonest form. Ménière's disease is characterised by recurrent vertigo with fluctuating hearing loss, tinnitus and/or aural fullness. Vestibular migraine can present with vertigo, visual sensitivity, headache, photophobia, phonophobia or nausea, and headache is not mandatory in every episode.
Vestibular neuritis generally presents with acute prolonged vertigo and imbalance without prominent hearing loss. Labyrinthitis may include auditory symptoms. Central causes include cerebellar infarction, brainstem infarction, demyelinating disease and other posterior fossa disorders.
Clinical Assessment and Differential Diagnosis
History should clarify what the patient means by dizziness, the onset, duration, frequency and triggers. Important associated symptoms include hearing loss, tinnitus, aural fullness, headache, photophobia, diplopia, dysarthria, weakness, numbness, gait disturbance, syncope and severe new headache. Examination may include blood pressure, pulse, otoscopy, eye movements, nystagmus, positional testing, gait and coordination, cranial nerves and a focused neurological examination.
Dix–Hallpike testing is important for suspected posterior-canal BPPV, while the supine roll test may help identify horizontal-canal disease. Audiometry and vestibular testing are appropriate in selected patients. MRI or vascular imaging is guided by clinical findings rather than performed routinely in every dizzy patient.
Urgent conventional assessment is required when vertigo is accompanied by focal neurological deficits, new severe headache, diplopia, dysarthria, limb weakness or numbness, marked truncal or gait ataxia, loss of consciousness, suspected stroke, acute unilateral hearing loss, progressive neurological symptoms or significant trauma. The principle is simple: therapeutic individualisation must never delay emergency evaluation.
Conventional Management in Clinical Context
Treatment depends on diagnosis. BPPV is principally treated with an appropriate canalith-repositioning manoeuvre. Vestibular rehabilitation is useful for selected patients with persistent vestibular dysfunction. Management of vestibular migraine and Ménière's disease is individualised according to current clinical guidance and specialist assessment. Central neurological disorders require cause-specific neurological management.
This diagnostic framework is relevant to complementary practice because persistent or recurrent vertigo should not be assumed to represent a single homogenous condition.
Homoeopathic Individualisation
Classical homoeopathic practice individualises the prescription according to the characteristic totality of symptoms. In vertigo, potentially useful dimensions include the exact sensation, direction of apparent movement, relation to head movement or posture, time of occurrence, modalities, concomitant nausea or vomiting, headache, auditory symptoms, visual symptoms, physical generals and mental symptoms.
A case described only as “vertigo” is therapeutically incomplete within a classical homoeopathic framework. For example, vertigo on turning the head differs symptomatically from vertigo associated with prolonged motion, digestive disturbance, visual sensitivity or anxiety. Repertorial analysis may be used after the case has been clearly characterised, followed by materia-medica confirmation and objective follow-up.
The medicine is selected based on individual symptom similarity rather than disease name alone.
Remedy | Individualizing Symptoms |
Conium maculatum | Vertigo associated with movement of the head or change of position. |
Cocculus indicus | Vertigo with nausea, motion sensitivity and weakness. |
Bryonia alba | Vertigo aggravated by movement, with desire for rest or stillness. |
Gelsemium sempervirens | Dizziness with heaviness, weakness and drowsiness. |
Nux vomica | Vertigo associated with headache, digestive disturbance and irritability. |
Phosphorus | Vertigo with visual and broader constitutional features. |
Argentum nitricum | Vertigo associated with anxiety and instability. |
Chininum sulphuricum / Salicylicum acidum | Traditional associations with periodic vertigo and auditory symptoms. |
Thuja Occidentalis | Vertigo, when closing the eyes |
Theridion | Vertigo: on closing the eyes,from any, even the least noise; aural or labyrinthine (Meniere's disease). |
Tabacum | Vertigo: death-like pallor, increases to loss of consciousness; relieved in open air and by vomiting; on rising or looking upward; on opening the eyes. |
Silicea | Vertigo: spinal, ascending from back of neck to head; as if one would fall forward, from looking up, |
Lachesis mutus | vertigo is typically characterized by dizziness and giddiness that occur or worsen upon waking from sleep, when closing the eyes, or while stooping. |
Ferrum Metallicum | Vertigo: with balancing sensation,, as if on water; on seeing flowing water; |
Tarentula hispanica | dizziness and severe vertigo—often severe enough to cause falling—worsened when descending stairs or occurring at night. |
These are traditional materia-medica descriptions, not rankings of clinical efficacy. Selection should depend on the complete individual case rather than on diagnosis alone.
Evidence for Homoeopathy in Vertigo
Direct clinical evidence for homoeopathy in vertigo is limited. A randomised double-blind study published in 1998 compared the complex preparation Vertigoheel with betahistine and reported improvement in both treatment groups. A subsequent controlled trial evaluated Vertigo heel in an elderly population with vertigo associated with atherosclerosis. A 2005 meta-analysis combined four clinical trials involving 1,388 participants and reported improvement in selected vertigo outcomes.
These studies concern a specific complex preparation and should not be interpreted as proof that classical individualised homoeopathy is effective for all vertigo syndromes. Broader systematic reviews of individualised and non-individualised homoeopathy have reported heterogeneous findings, with methodological limitations and variation in interventions, controls and outcomes. Contemporary methodological recommendations emphasise transparent reporting, appropriate risk-of-bias assessment and clearly defined research questions.
Consequently, the most defensible conclusion is that preliminary clinical research exists, but the evidence base remains insufficient to establish homoeopathy as an evidence-proven treatment for vertigo across diagnostic categories.
Safety, Monitoring and Outcome Assessment
Homoeopathic care should not delay referral or established treatment when clinically indicated. Patients should be reassessed when symptoms persist, worsen, change character or develop new neurological or auditory features. Baseline and follow-up documentation should include episode frequency, duration, severity, falls, nausea, tinnitus, hearing symptoms, functional limitation, quality of life and concurrent medication use.
Future studies should use validated dizziness-related outcome measures and should report the exact homoeopathic intervention, potency, dosing, prescribing method, co-interventions and adverse events. This would allow meaningful comparison and replication.
Discussion
Vertigo illustrates both the potential usefulness and the limitations of integrating traditional individualisation with contemporary clinical medicine. Detailed homoeopathic case-taking can capture subjective characteristics that may be important to the patient, but these characteristics do not eliminate the need to identify the underlying disease. BPPV, vestibular migraine, Ménière's disease, vestibular neuritis and central disorders differ substantially in mechanism and management.
A scientifically responsible publication must distinguish historical materia-medica claims from clinical evidence. A remedy appearing in materia medica is not, by itself, evidence of therapeutic efficacy. Similarly, improvement in an uncontrolled case may reflect natural history, regression to the mean, placebo/contextual effects or concurrent treatment. Better trials are therefore required.
Research should enrol clearly diagnosed populations, predefine outcomes, report individualised prescribing transparently and include clinically relevant follow-up. Collaboration among homoeopathic physicians, neurologists, otorhinolaryngologists and vestibular rehabilitation specialists may improve both safety and scientific quality.
Conclusion
Vertigo is a symptom with a broad differential diagnosis and variable clinical significance. Accurate assessment based on timing, triggers, associated features and focused examination is essential. Red flags require urgent conventional evaluation. Homoeopathic practice may individualise treatment according to characteristic symptoms after appropriate clinical assessment, but the present evidence base is limited and heterogeneous. Selected studies of complex preparations cannot be equated with proof of classical individualised homoeopathy. Future well-designed research is required before stronger therapeutic conclusions can be made.
